Impact Factor
3.76
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.22
737 total citations
h5-index
31
h5 depth signal
Cited share
84.8%
156 of 184
Total citations
737
Citation footprint
Metric signal
4.58
External metric anchor
Self-citation
1.1%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
439
United States
97
Iran
91
Egypt
78
Saudi Arabia
53
Citing Fields of Research
Pharmacology & Toxicology
304
Molecular & Cellular Toxicology
112
Cardiology
94
Antibiotic & Antibacterial Agents
78
Diabetes
74
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,695
Articles tracked across the journal lifetime
Indexed publication set
184
156 cited publications
Last 12 months
237
19.8 publications/month
Open access share
100.0%
237 OA publications in the last year
Leading citing country
China
439 citing publications
Leading citing field
Pharmacology & Toxicology
304 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v13, 2012-
v13, 2012-
Active Coverage
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Molecular & Cellular Toxicology
Cardiology
Antibiotic & Antibacterial Agents
Drug Delivery Systems
Diabetes
Broad Categories
Pharmacology
Toxicology
Medical Ethics
Drug Delivery Systems
Cardiology
Hematology
Pharmacology & Toxicology
Antibiotic & Antibacterial Agents
Agrochemicals & Ground Poisoning
MeSH Descriptors
Pharmaceutical Preparations
Pharmacology, Clinical
Toxicology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1186/s40360-026-01198-w
Open DOI
When drug repurposing backfires: antagonistic effects of ivermectin on cisplatin therapy in oral cancer
02
DOI 10.1186/s40360-026-01263-4
Open DOI
Pregnancy outcome after first-trimester exposure to JAK inhibitors - an evaluation of the German Embryotox cohort
Background: Janus kinase inhibitors (JAKi) are increasingly being used in the management of autoimmune diseases across rheumatology, gastroenterology, and dermatology, including in women of childbearing age. Consequently, pregnancies occ...
03
DOI 10.1186/s40360-026-01255-4
Open DOI
Implementing a CYP2C19-guided approach for prescribing dual antiplatelet therapy in acute coronary syndrome for patients undergoing percutaneous coronary intervention: a cost-effectiveness analysis
Background: Prescribing guidelines recommend prasugrel or ticagrelor with aspirin as dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS), with clopidogrel reserved for peo...
04
DOI 10.1186/s40360-026-01262-5
Open DOI
Early atherosclerotic phenotypic alterations induced by PFOS exposure: a network toxicology and zebrafish model study
05
06
07
DOI 10.1186/s40360-026-01251-8
Open DOI
Risk factors and clinical implications of QTc prolongation in methadone maintenance therapy: a systematic review
Objective: Methadone, a synthetic opioid agonist widely used for opioid substitution therapy and chronic pain management, has been increasingly associated with concerns regarding cardiac safety, particularly QTc prolongation and its pote...
08
DOI 10.1186/s40360-026-01258-1
Open DOI
Dexpanthenol attenuates anxiety-like behaviors and inflammatory factors in a rat model of acetic acid-induced colitis
09
DOI 10.1186/s40360-026-01206-z
Open DOI
Efficacy and safety of palonosetron versus ondansetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomised controlled trials
Background: 5-hydroxytryptamine type 3 receptor antagonists (5HT₃RAs) are widely used to prevent chemotherapy-induced nausea and vomiting (CINV). Although previous meta-analyses have demonstrated that palonosetron offers superior efficac...
10
DOI 10.1186/s40360-026-01260-7
Open DOI
Agomelatine attenuates the expression of nicotine-induced locomotor sensitization in male rats
Bibliographical & Catalog Notes
Formed by the union of: BMC clinical pharmacology; and BMC pharmacology, and continues the numbering of the former.